top of page



About the book

About The Longevity Industry 1.0 Book

The book features first of its kind coverage of entirely new segments and sectors of the rising Longevity Industry, including Longevity Politics and Governance, the Longevity Financial Industry (including coverage of AgeTech, WealthTech, FinTech, and the coming rise of new financial instruments and derivatives), the current state and forecasts on the Global Industrialization of Longevity to Scale, and an overview of the near-future trajectory of the Longevity Industry’s  evolution 2020- 2025.

2010-2020: Evolution of the Longevity

Industry from Zero to 1.0

  • The Industrialization of Longevity

  • The Current State of Longevity Science, Business, Finance, and Practical Applications

  • Longevity Becomes National Priority Item for the Strategic Agenda of Progressive Governments

  • Transforming the Challenge and Deficit of Aging into the Opportunity and Asset of Longevity

  • Defining and De-Risking: Hype vs. Reality

2020-2025: DeepTech Engineering The Accelerated Trajectory of Human Longevity - The Blueprint and Pathway from 1.0 to 2.0

  • Global Industrialization of Longevity to Scale

  • The Evolution from Longevity Start-ups to Multi-Trillion Dollar Longevity Corporations

  • How AI-Driven Preventive Medicine will Disrupt BioTech and Healthcare Industries 

  • Novel Financial Instruments and InvestTech Solutions

  • The Rise of Progressive Longevity MegaHubs

PART I. Longevity Industry Mega-Complexity

Longevity Industry Mega-Complexity

Challenges, Issues, Opportunities

  • The Unprecedented Complexity, Intersectionality and Multidimensionality of the Longevity Industry

  • Why Traditional Methods of BioTech Analytics, Forecasting, Benchmarking and Investment Strategy Will Fail For Longevity

  • The Need for New Analytical Methodologies and Frameworks Equal to the Complexity of the Longevity Industry

  • Longevity.Capital: Specialized Hybrid Investment Fund for Longevity-Industry De-Risking and Diversification

PART II. Longevity Policy and Governance

Longevity Policy and Governance

Longevity Technocracies & MegaHubs

  • The Rise of Progressive Longevity MegaHubs and Technocracies

  • Longevity as Major National Priority Item of Progressive Governments’ Strategic Agendas

  • The Emergence of Longevity-Focused Parliamentary Groups and Government Bodies

  • National Longevity Industrial Strategies and Healthy Longevity Development Plans

  • How Longevity Will Determine the Outcome of National Elections by the Year 2025

PART III. Longevity Financial Industry

The Longevity Financial Industry

Novel Longevity Derivatives and Health as New Wealth

  • The Increasing Role of Longevity in Global Finance

  • Longevity Embraced by the World’s Biggest Financial Corporations: Investment Banks, Insurance Companies, Asset Management Firms

  • Longevity Derivatives: New Business Models and Novel Financial Instruments Tied to the Rising Longevity Industry

  • AgeTech, WealthTech, FinTech

  • Why Traditional BioTech Analytics Fails  Against the Longevity Industry's Extreme Complexity

PART IV. Longevity Industry (Science and Biomedicine)

Longevity Industry
Global Industrialization of Longevity

  • Global Industrialization of Longevity to Scale 

  • Biggest and Most Complex Industry in Human History

  • The Need for Novel, Complex, Multidimensional Analytical Frameworks and De-Risking Methods

  • The Evolution from Longevity Start-ups to Multi-Trillion Dollar Longevity Corporations

  • How AI-driven Preventive Medicine and Novel InvestTech Solutions Will Disrupt BioTech and Healthcare Industries by 2025

About the Author

About the authors


Dmitry Kaminskiy is an innovative entrepreneur and investor, active in the fields of Longevity, Precision Medicine, and Artificial Intelligence. He is a co-founder and managing partner at Deep Knowledge Ventures, a leading investment fund focused on DeepTech, renowned for its use of sophisticated analytical systems for investment target identification and due diligence. He is a frequent speaker on AI and Longevity, including events organized in London by The Economist ("Aging Societies and The Business of Longevity") and organized by the Financial Times ("Smart Machines vs. Smart People" and "Global Pharmaceutical and Biotechnology Conference"), as well as the "Precision Medicine World Conference" in Silicon Valley, and other events at Oxford and Cambridge universities. He is actively involved in the work of the initiative group and was instrumental in the initial stage of the launch of the All-Party Parliamentary Group for Longevity in the UK Parliament. He now serves as co-director of the secretariat, overseeing the APPG's international Longevity cooperation development division.

A big thank you to the book co-author Margaretta Colangelo and to the book contributors:

Sergey Balasanyan, Kate Batz, Franco Cortese, Robin Farmanfarmaian, Stefan Hascoet, Eric Kihlstrom, Richard Siow.

bottom of page